Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.